# Premarket Approval (PMA) | Botable Glossary

https://www.botable.ai/glossary/premarket-approval-pma

> A concise explanatory glossary entry on PMA from Botable; useful as a high-level reference on regulatory expectations. Treat it as an explanatory summary rather than primary legal or regulatory text — verify regulatory or legal requirements directly from the FDA when making compliance decisions.

## Summary

The page defines Premarket Approval (PMA) as the FDA's most stringent regulatory application for Class III medical devices, describes what a PMA must contain, explains the FDA review and approval process (including filing, typical 180‑day review, possible decisions), and outlines post-approval supplement and monitoring requirements.

## Audience

Professionals involved in medical device regulation, quality, and regulatory affairs

## Prompts this page answers

- What is Premarket Approval (PMA) and when is it required?
- What must be included in a PMA submission to the FDA?
- How long does the FDA typically take to review a PMA and what decisions can it issue?
- When is a PMA supplement required and what triggers post-approval monitoring?

## Purpose

To explain what a Premarket Approval (PMA) is, when it is required, what must be included in a PMA submission, how the FDA reviews PMAs, and the post-approval obligations for approved devices.

## Highlights

- PMA is the FDA's most stringent regulatory pathway and is required for Class III (high-risk) medical devices.
- A PMA application must include organization/indexing, nonclinical and clinical study sections, labeling, marketing history, risk/benefit analysis, and a concluding justification demonstrating valid scientific evidence of safety and effectiveness.
- FDA notifies applicants within 45 days whether a PMA is filed; the standard review period after filing is typically 180 days, though it can be extended for major amendments.
- FDA outcomes include Approval Order, Approvable Letter, Not Approvable Letter, or Denial Order; denial grounds include false statements or noncompliance with inspections or clinical investigation requirements.
- After approval, significant changes affecting safety or effectiveness require submission of a PMA supplement; failure to meet post-approval requirements can lead to withdrawal of approval.

## How to cite

Botable Glossary — "Premarket Approval (PMA)" (https://www.botable.ai/glossary/premarket-approval-pma)

## Publisher



## Topics

- Premarket Approval
- PMA
- Class III medical device
- FDA review
- PMA supplement

## Key entities

- **U.S. Food and Drug Administration** (organization): Regulatory agency that reviews and approves PMA applications (referred to throughout the page as FDA).
- **Premarket Approval (PMA)** (other): The glossary term defined on the page. — https://www.botable.ai/glossary/premarket-approval-pma
- **Class III medical device** (other): Device classification for which PMA is required (as stated on the page).
- **Product Development Protocol (PDP)** (other): An alternative mechanism mentioned as satisfying device requirements in lieu of an approved PMA.

## Metadata

- Type: article